Green Elephant Biotech is the world's first company to develop, produce, and distribute lab consumables made from plant-based plastics. With its innovative and sustainable products, Green Elephant ...
10h
Asian News International on MSNIIT Guwahati signs technology transfer MoU for low-cost, high-yield C-phycocyanin production technologySpeaking about IIT Guwahati's commitment to developing cutting-edge biotechnologies, Prof. Devendra Jalihal, Director, IIT Guwahati, said, "IIT Guwahati is committed to advancing research that creates ...
In an interview with the North Carolina Biotechnology Center, Zarur said GreenLight’s ... GreenLight’s technology platform develops products that attack only the targeted pest and are harmless to ...
The U.S. IPO activity looks sluggish amid the holiday-shortened week. Nevertheless, the week prior saw Texas-based cybersecurity firm SailPoint price its upsized IPO of 60M shares at a public offering ...
Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...
The expanded collaboration between BRAIN Biotech and PX Group is a key part of the PX Urban Mining Initiative, an industry and academic network focused on developing and implementing disruptive, ...
China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, ...
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Products Index. The Index seeks to track the ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...
Risk Adjusted Net Present Value Method Developing drugs and biotech products are expensive, time-consuming and risky propositions. With multiple stages of testing, clinical trials and regular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results